These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Kornum BR; Faraco J; Mignot E Curr Opin Neurobiol; 2011 Dec; 21(6):897-903. PubMed ID: 21963829 [TBL] [Abstract][Full Text] [Related]
23. Narcolepsy and H1N1 vaccination: a link? Thebault S; Vincent A; Gringras P Curr Opin Pulm Med; 2013 Nov; 19(6):587-93. PubMed ID: 24048081 [TBL] [Abstract][Full Text] [Related]
24. Epidemiology and Pathophysiology of Childhood Narcolepsy. Dye TJ; Gurbani N; Simakajornboon N Paediatr Respir Rev; 2018 Jan; 25():14-18. PubMed ID: 28108192 [TBL] [Abstract][Full Text] [Related]
25. [Narcolepsy as an autoimmune disease]. Sarkanen T; Vaarala O; Julkunen I; Partinen M Duodecim; 2015; 131(12):1153-60. PubMed ID: 26245045 [TBL] [Abstract][Full Text] [Related]
26. Conserved peptides containing overlapping CD4+ and CD8+ T-cell epitopes in the H1N1 influenza virus: an immunoinformatics approach. Lohia N; Baranwal M Viral Immunol; 2014 Jun; 27(5):225-34. PubMed ID: 24821387 [TBL] [Abstract][Full Text] [Related]
27. [Narcolepsy with cataplexy: an autoimmune disease?]. Jacob L; Dauvilliers Y Med Sci (Paris); 2014 Dec; 30(12):1136-43. PubMed ID: 25537044 [TBL] [Abstract][Full Text] [Related]
28. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Heier MS; Gautvik KM; Wannag E; Bronder KH; Midtlyng E; Kamaleri Y; Storsaeter J Sleep Med; 2013 Sep; 14(9):867-71. PubMed ID: 23773727 [TBL] [Abstract][Full Text] [Related]
29. A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis. Lind A; Marzinotto I; Brigatti C; Ramelius A; Piemonti L; Lampasona V Sci Rep; 2021 Feb; 11(1):4063. PubMed ID: 33603024 [TBL] [Abstract][Full Text] [Related]
30. Potential T cell epitopes within swine-origin triple reassortant influenza A (H3N2) variant virus which emerged in 2011: an immunoinformatics study. Duvvuri VR; Marchand-Austin A; Eshaghi A; Patel SN; Low DE; Gubbay JB Vaccine; 2012 Sep; 30(42):6054-63. PubMed ID: 22877860 [TBL] [Abstract][Full Text] [Related]
31. Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ? Lecendreux M; Libri V; Jaussent I; Mottez E; Lopez R; Lavault S; Regnault A; Arnulf I; Dauvilliers Y J Autoimmun; 2015 Jun; 60():20-31. PubMed ID: 25892508 [TBL] [Abstract][Full Text] [Related]
32. Retraction of the letter: "Comment on 'CD4⁺ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy' ". van der Most R; Wettendorff M; Innis B; Hanon E Sci Transl Med; 2014 Sep; 6(255):255rt2. PubMed ID: 25253677 [No Abstract] [Full Text] [Related]
33. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Partinen M; Kornum BR; Plazzi G; Jennum P; Julkunen I; Vaarala O Lancet Neurol; 2014 Jun; 13(6):600-13. PubMed ID: 24849861 [TBL] [Abstract][Full Text] [Related]
34. Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutinin. Subbramanian RA; Basha S; Brady RC; Hazenfeld S; Shata MT; Bernstein DI Hum Immunol; 2010 Oct; 71(10):957-63. PubMed ID: 20650295 [TBL] [Abstract][Full Text] [Related]
35. Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus. Rodríguez-Alvarez M; Velasco-Velasco AM; Alvarez-Anell NJ; Jiménez-Corona ME; de León-Rosales SP Arch Med Res; 2009 Nov; 40(8):687-92. PubMed ID: 20304258 [TBL] [Abstract][Full Text] [Related]
36. Narcolepsy and A(H1N1)pdm09 vaccination: shaping the research on the observed signal. van der Most R; Van Mechelen M; Destexhe E; Wettendorff M; Hanon E Hum Vaccin Immunother; 2014; 10(3):572-6. PubMed ID: 24342916 [TBL] [Abstract][Full Text] [Related]
37. A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden. Feltelius N; Persson I; Ahlqvist-Rastad J; Andersson M; Arnheim-Dahlström L; Bergman P; Granath F; Adori C; Hökfelt T; Kühlmann-Berenzon S; Liljeström P; Maeurer M; Olsson T; Örtqvist Å; Partinen M; Salmonson T; Zethelius B J Intern Med; 2015 Oct; 278(4):335-53. PubMed ID: 26123389 [TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy. Knudsen S; Mikkelsen JD; Bang B; Gammeltoft S; Jennum PJ Neuropediatrics; 2010 Oct; 41(5):217-22. PubMed ID: 21210337 [TBL] [Abstract][Full Text] [Related]
39. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Liblau RS; Vassalli A; Seifinejad A; Tafti M Lancet Neurol; 2015 Mar; 14(3):318-28. PubMed ID: 25728441 [TBL] [Abstract][Full Text] [Related]
40. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011. Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]